Read Article
Related Articles
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.
Nguyen LN
et al.
Nature
2014
Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development.
Wong BH
et al.
Journal of Biological Chemistry
2016
Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A.
Quek DQ
et al.
Journal of Biological Chemistry
2016
Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome
Alicia Guemez-Gamboa 1
et al.
Nature Genetics
2015
A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome
Vafa Alakbarzade
et al.
Nature Genetics
2015
Insights into major facilitator superfamily domain-contaning protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?
Eser Ocak P
et al.
Journal of Neuroscience Research
2020
Mfsd2a is critical for the formation and function of the blood-brain barrier
Ayal Ben-Zvi
et al.
Nature
2014
Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism
Justin H Berger
et al.
PLoS ONE
2012
The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8 + Memory T Cell Maintenance and Secondary Response to Infection
Ann R Piccirillo
et al.
J Immunol
2019
Lysophosphatidylcholine as a carrier of docosahexaenoic acid to target tissues
M Lagarde
et al.
World Rev Nutr Diet
2001
Plasma BDNF is a more reliable biomarker than erythrocyte omega-3 index for the omega-3 fatty acid enrichment of brain
Dhavamani Sugasini
et al.
Scientific Reports
2020
Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis
Benjamin J Andreone
et al.
Neuron
2017
Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis
Benjamin J Andreone
et al.
Neuron
2017
Gradual Suppression of Transcytosis Governs Functional Blood-Retinal Barrier Formation
Brian Wai Chow
et al.
Neuron
2017
The Cellular and Molecular Landscapes of the Developing Human Central Nervous System
John C Silbereis
et al.
Neuron
2016
Blood-brain barrier: a dual life of MFSD2A?
Zhao Z
et al.
Neuron
2014
Lipidomics reveals a remarkable diversity of lipids in human plasma
Oswald Quehenberger
et al.
J Lipid Res.
2010
A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2
Cécile Esnault
et al.
Proc Natl Acad Sci USA
2008
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat
M Croset
et al.
Biochem J.
2000
The uptake and metabolism of plasma lysophosphatidylcholine in vivo by the brain of squirrel monkeys
D R Illingworth, O W Portman
et al.
Biochem J .
1972
Transport of lysolecithin by albumin in human and rat plasma
S Switzer
et al.
The Journal of Lipid Research
1965
Metabolism of glycerolipids. 2. The enzymatic acylation of lysolecithin
Lands W E
et al.
J Biol Chem.
1960
Biochem J . 2000 Jan 1;345 Pt 1(Pt 1):61-7.

Characterization of plasma unsaturated lysophosphatidylcholines in human and rat

January 1, 2000
M Croset 1, N Brossard, A Polette, M Lagarde
  1. INSERM U 352, Biochimie et Pharmacologie INSA-Lyon, Bât. 406, 20, Ave A. Einstein, 69621 Villeurbanne, France.
Abstract

Unsaturated lysophosphatidylcholines (lysoPtdCho) bound to albumin circulate in blood plasma and seem to be a novel transport system for carrying polyunsaturated fatty acids (PUFA) to tissues that are rich in these fatty acids, such as the brain. The potential of these lysoPtdCho as a significant source of PUFA for cells has been assessed by comparing their plasma concentration with that of unsaturated non-esterified fatty acids (NEFA) bound to albumin. In humans, the PUFA concentration was 25.9+/-3.1 nmol/ml for these lysoPtdCho, compared with 33.4+/-9.6 nmol/ml for NEFA; in rats the equivalent values are 14.2+/-0.6 and 13.1+/-1.1 nmol/ml respectively (means+/-S.E.M.). The lysoPtdCho arachidonic acid content was 2-fold (human) and 5-fold (rat) higher than that of NEFA. In human and rat plasma, unsaturated lysoPtdCho were associated mainly with albumin rather than lipoproteins. The rate and extent of the acyl group shift from the sn-2 to sn-1 position of these lysoPtdCho were studied by the incubation of 1-lyso, 2-[(14)C]C(18:2)n-6-glycerophosphocholine (GPC) with plasma. The rapid isomerization of this lipid occurred at pH 7 (20% isomerization within 2 min) and was not prevented by its association with albumin. The position of the acyl group in the lysoPtdCho circulating in plasma was studied by collecting blood directly in organic solvents containing 1-lyso,2-[(14)C]C(18:2)n-6-GPC as a marker of isomerization that occurred during sampling and analysis. Approx. 50% of the PUFA was located at the sn-2 position, demonstrating that substantial concentrations of 2-acyl-lysoPtdCho are present in plasma and are available for tissue uptake, where they can be reacylated at the sn-1 position to form membrane phospholipids.

Keywords
LPC
Lysolipids
Lysophospholipid
RELATED